Clinical and pathological factors related to brain relapse–free survival in breast cancer patients

I want to congratulate Li and colleagues for their article [1] in which they did a comprehensive analysis in 108 consecutive patients with breast cancer brain metastases to define clinicopathologic factors associated with early onset of brain metastasis and survival outcomes after development of them. Of these patients, 16% were metastatic (stage IV disease) at initial diagnosis.

http://ift.tt/2sVOfib